Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 241

Similar articles for PubMed (Select 21177768)

1.

Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells.

Macha MA, Matta A, Chauhan SS, Siu KW, Ralhan R.

Carcinogenesis. 2011 Mar;32(3):368-80. doi: 10.1093/carcin/bgq278. Epub 2010 Dec 22.

2.

Guggulsterone targets smokeless tobacco induced PI3K/Akt pathway in head and neck cancer cells.

Macha MA, Matta A, Chauhan SS, Siu KW, Ralhan R.

PLoS One. 2011 Feb 24;6(2):e14728. doi: 10.1371/journal.pone.0014728.

3.

Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-{kappa}B subunits in head and neck cancer.

Allen C, Saigal K, Nottingham L, Arun P, Chen Z, Van Waes C.

Clin Cancer Res. 2008 Jul 1;14(13):4175-85. doi: 10.1158/1078-0432.CCR-07-4470.

4.

A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.

Lee TL, Yeh J, Friedman J, Yan B, Yang X, Yeh NT, Van Waes C, Chen Z.

Int J Cancer. 2008 May 1;122(9):1987-98. doi: 10.1002/ijc.23324.

PMID:
18172861
5.

Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco.

Sawhney M, Rohatgi N, Kaur J, Shishodia S, Sethi G, Gupta SD, Deo SV, Shukla NK, Aggarwal BB, Ralhan R.

Int J Cancer. 2007 Jun 15;120(12):2545-56.

PMID:
17354234
6.

Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.

Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM, Aggarwal BB.

Oncogene. 2007 Mar 1;26(10):1385-97. Epub 2006 Sep 4.

PMID:
16953224
7.

Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.

Squarize CH, Castilho RM, Sriuranpong V, Pinto DS Jr, Gutkind JS.

Neoplasia. 2006 Sep;8(9):733-46.

9.
10.

Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma.

Yan M, Xu Q, Zhang P, Zhou XJ, Zhang ZY, Chen WT.

BMC Cancer. 2010 Aug 17;10:437. doi: 10.1186/1471-2407-10-437.

11.

Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling.

Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB.

Int J Cancer. 2004 Sep 20;111(5):679-92. Erratum in: Int J Cancer. 2004 Dec 20;112(6):1086.

PMID:
15252836
12.

Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells.

Sharma C, Kaur J, Shishodia S, Aggarwal BB, Ralhan R.

Toxicology. 2006 Nov 10;228(1):1-15. Epub 2006 Aug 12.

PMID:
16996673
13.

Curcumin inhibits carcinogen and nicotine-induced Mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma.

Clark CA, McEachern MD, Shah SH, Rong Y, Rong X, Smelley CL, Caldito GC, Abreo FW, Nathan CO.

Cancer Prev Res (Phila). 2010 Dec;3(12):1586-95. doi: 10.1158/1940-6207.CAPR-09-0244. Epub 2010 Sep 17.

14.

Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma.

Li F, Shanmugam MK, Chen L, Chatterjee S, Basha J, Kumar AP, Kundu TK, Sethi G.

Cancer Prev Res (Phila). 2013 Aug;6(8):843-54. doi: 10.1158/1940-6207.CAPR-13-0070. Epub 2013 Jun 26.

15.

NS-398 induces apoptosis in human esophageal cancer cells through inhibition of NF-kappaB downstream regulation of cyclooxygenase-2.

Liu JF, Zhu GJ, Jamieson GG, Wu TC, Zhu TN, Shan BE, Drew PA.

Cancer Invest. 2009 Jan;27(1):17-23. doi: 10.1080/07357900801992913.

PMID:
19160097
16.
17.
19.

Enhanced IkappaB kinase activity is responsible for the augmented activity of NF-kappaB in human head and neck carcinoma cells.

Tamatani T, Azuma M, Aota K, Yamashita T, Bando T, Sato M.

Cancer Lett. 2001 Oct 10;171(2):165-72.

PMID:
11520600
20.

Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3.

Leeman-Neill RJ, Wheeler SE, Singh SV, Thomas SM, Seethala RR, Neill DB, Panahandeh MC, Hahm ER, Joyce SC, Sen M, Cai Q, Freilino ML, Li C, Johnson DE, Grandis JR.

Carcinogenesis. 2009 Nov;30(11):1848-56. doi: 10.1093/carcin/bgp211. Epub 2009 Sep 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk